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Purpose:  To  report  the  diffusion-weighted  MRI  ﬁndings  in  alveolar  echinococcosis  (AE)  of  the  liver and
evaluate  the  potential  role  of  apparent  diffusion  coefﬁcients  (ADCs)  in the  characterisation  of  lesions.
Materials  and  methods:  We  retrospectively  included  22  patients  with  63  AE liver lesions  (≥1 cm),  exam-
ined  with  3-T  liver  MRI,  including  a free-breathing  diffusion-weighted  single-shot  echo-planar  imaging
sequence  (b-values  = 50, 300 and 600  s/mm2). Two  radiologists  jointly  assessed  the  following  lesion  fea-
tures:  size,  location,  presence  of  cystic  and/or  solid components  (according  to Kodama’s  classiﬁcation
system),  relative  contrast  enhancement,  and  calciﬁcations  (on  CT).  The  ADCtotal, ADCmin and  ADCmax were
measured  in  each  lesion  and  the surrounding  liver  parenchyma.
Results:  Three  type  1, 19  type  2, 17 type  3, three type  4  and 21  type  5 lesions  were  identi-
ﬁed.  The  mean  (±SD)  ADCtotal, ADCmin and  ADCmax for  all  lesions  were  1.73 ±  0.50,  0.76  ±  0.38  and
2.63  ±  0.76  × 10−3 mm2/s, respectively.  The  mean  ADCtotal for  type  1, type  2, type  3,  type  4  and  type
5 lesions  were  1.97  ±  1.01,  1.76  ±  0.53,  1.73 ±  0.41, 1.15  ±  0.42  and  1.76  ±  0.44  × 10−3 mm2/s,  respec-
tively.  No signiﬁcant  differences  were  found  between  the  ﬁve  lesion  types,  except  for  type  4  (p =  0.0363).
There  was  a  signiﬁcant  correlation  between  the  presence  of a  solid component  and  low  ADCmin (r  =  0.39,
p =  0.0016),  whereas  an  inverse  correlation  was  found  between  the  relative  contrast  enhancement  and
ADCtotal (r =  −0.34,  p =  0.0072).
Conclusion:  The  ADCs  of  AE lesions  are  relatively  low  compared  to  other  cystic  liver  lesions,  which  may
help  in  the  differential  diagnosis.  Although  ADCs  are of little  use  to  distinguish  between  the ﬁve lesion
types,  their  low  value  reﬂects  the underlying  solid  component.
he  A© 2014  T
. Introduction
Alveolar echinococcosis (AE) is a rare zoonosis caused by the
arval stage of the tapeworm Echinococcus multilocularis [1]. This
hronic and life-threatening disease is conﬁned to the northern
emisphere, typically found in endemic regions of western and cen-
ral Europe, as well as central and eastern Asia, particularly China
1–3]. Mainly transmitted by the fox, which disseminates parasite
ggs through the faeces, the metacestodes of E. multilocularis ini-
ially grow in the liver of infected humans by external vesiculation
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[3,4]. The uni- or multilocular cysts are surrounded by an intense
ﬁbroinﬂammatory host response, and AE lesions eventually invade
the portal and/or hepatic veins, as well as intrahepatic bile ducts.
They can also extend to extrahepatic sites, such as the spleen and
lungs [4,5].
Imaging plays an important role in the diagnosis of AE, since
the latter is based on the results of cross-sectional imaging,
immunoserology, histopathology and/or detection of species-
speciﬁc deoxyribonucleic acid on metacestode samples [3,4].
Ultrasonography (US) is generally the ﬁrst-line examination and
usually complemented by computed tomography (CT) and/or mag-
netic resonance imaging (MRI) [4–7]. While the typical calciﬁcation
pattern is best depicted on CT, MRI  demonstrates more accurately
the characteristic multivesicular appearance of AE lesions, necrotic
Open access under CC BY-NC-ND license.areas and invasion of vascular, biliary and/or extrahepatic struc-
tures [4–7]. To systematise the various imaging features and gain
insight into the disease pathophysiology, Kodama et al. proposed
a MRI  classiﬁcation system for AE liver lesions [8]. They were
-NC-ND license.
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(ig. 1. Illustrative diagram of Kodama’s classiﬁcation system for AE liver lesions (a
ithout (type 1) or with (type 2) a solid component (grey). Type 3 lesions are compo
nd/or  irregular cyst(s). Type 4 lesions consist of a solid component without cyst, w
ategorised into ﬁve types, according to the presence of cystic
nd/or solid components, the pattern of the cystic component, and
he distribution pattern of those two components in the lesions
Fig. 1). However, due to their ill-deﬁned contours and inﬁltrative
rowth pattern, AE lesions may  mimic  primary or secondary liver
eoplasms [4,5].
Diffusion-weighted MRI  (DWI) is based on the random micro-
copic motion of water protons and enables qualitative and
uantitative assessment of tissue diffusivity by means of the appar-
nt diffusion coefﬁcient (ADC) [9,10]. DWI  is increasingly used in
bdominal MRI, particularly to detect and characterise focal liver
esions (FLLs) [10–12]. A few recent studies have demonstrated its
alue in the evaluation of cystic echinococcosis of the liver (caused
y Echinococcus granulosus)  [13–16]. To our knowledge, no study
nvestigating the value of DWI  in liver AE has been performed so
ar.
Thus, the purpose of our study was to report the DWI  ﬁndings
n liver AE and evaluate the potential role of ADCs in the character-
sation of lesions.
. Materials and methods
.1. Patients
By searching in the radiological and surgical databases (search
erms: alveolar echinococcosis, liver, MRI; search period: January
008 to May  2013) of Lausanne University Hospital, a total of 29
atients examined with liver MRI  for suspected AE were ﬁrstly
dentiﬁed. Five patients had to be excluded because the initial MRI
can did not include diffusion-weighted sequences, whereas two
dditional patients had no preoperative MRI. Hence, the ﬁnal study
opulation consisted of 22 patients (14 women, 8 men; mean age 63
ears, range 22–82) with liver AE, whose diagnosis was conﬁrmed
y immunoserology (n = 21), surgery with subsequent pathological
nalysis (gross and microscopic examinations, n = 15) and/or sug-
estive cross-sectional imaging ﬁndings on initial and follow-up
xaminations. Three patients had an underlying liver disease (one
brosis, one cirrhosis and one haemosiderosis) conﬁrmed by intra-
perative biopsy of the surrounding liver parenchyma, whereas all
thers (n = 19) had a normal liver on imaging and/or intraoperative
iopsy (n = 12). Besides, 21 patients had a previous CT scan avail-
ble for review (18 performed within one month of the MRI), while
2 had a previous US.
This single-centre retrospective study was approved by the
nstitutional ethics committee, with waiver of patient informed
onsent. It was carried out in accordance with The Code of Ethics
f the World Medical Association (Declaration of Helsinki) for exper-
ments involving humans.
.2. MRI  protocolAll MRI  scans were performed on one of two  3-T systems
Magnetom Trio or Verio; Siemens Healthcare, Erlangen, Germany)
ith maximum gradient strengths of 45 mT/m and slew rates of from [8]). Type 1 and type 2 lesions consist of multiple small round cysts (white)
f multiple small round cysts with a solid component surrounding one or more large
s type 5 a large and/or irregular cyst without solid component.
200 T/m/s, using two 6-channel phased-array body coils anteri-
orly and two  3-channel spine clusters posteriorly. We used our
routine liver MRI  protocol but only the following axial pulse
sequences were reviewed for the study purpose: breath-hold
T2-weighted half-Fourier acquisition single-shot turbo spin-echo
(HASTE; repetition time (TR)/echo time (TE), 1200/89 ms; echo-
train length (ETL), 256; number of excitations (NEX), 1; matrix
size, 320 × 240; section thickness/gap, 3/0.3 mm); respiration-
triggered fat-suppressed (FS) T2-weighted turbo spin-echo (TR/TE,
5300/88 ms  (dependent on the respiratory rate); ETL, 15; NEX,
3; matrix size, 448 × 336; section thickness/gap, 5/1.5 mm); free-
breathing FS DW single-shot echo-planar imaging (DW-SS-EPI;
TR/TE, 6500/66 ms;  ETL, 1; receiver bandwidth, 1698 Hz/pixel;
NEX, 3; matrix size, 168 × 126; section thickness/gap, 6/1.8 mm);
and breath-hold dynamic (arterial, portal venous and equilibrium
phases) gadolinium-enhanced (Dotarem, 0.2 ml/kg (0.1 mmol/kg)
of body weight, followed by normal saline ﬂush; Guerbet,
Villepinte, France) FS three-dimensional T1-weighted gradient-
echo (volume interpolated breath-hold examination, VIBE; TR/TE,
4.6/1.7 ms;  ETL, 1; ﬂip angle, 9◦; NEX, 1; matrix size, 448 × 336;
section thickness/gap, 4/0.8 mm).
All those sequences were performed using the generalised
autocalibrating partially parallel acquisition (GRAPPA) technique
with an acceleration factor of 2. The DWI-SS-EPI sequence was
acquired before intravenous administration of contrast medium,
with the patient breathing freely but shallowly. Fat suppression
was achieved using the spectrally adiabatic inversion recovery
(SPAIR) technique. The diffusion gradients were applied in three
orthogonal directions (section, phase and frequency encoding
directions), with increasing b-values of 50, 300 and 600 s/mm2.
These b-values were selected for the same reasons as described
elsewhere (higher contrast-to-noise ratio, while limiting pseudod-
iffusion/perfusion effects [11,17]). Trace images were synthesised
for each b-value and the corresponding ADC map  automatically
generated from all diffusion weightings and directions, with a noise
level set to 10. The voxel size of the DWI-SS-EPI sequence was
2.3 mm × 2.3 mm × 6.0 mm and acquisition time approximately
7 min.
2.3. Image analysis
All MRI  and CT examinations were reviewed by two radiologists
(with 8 and 3 years of experience in abdominal MRI, respectively)
on a picture archiving and communication system (PACS) worksta-
tion (Carestream Vue, version 11.3; Carestream Health, Rochester,
NY, USA), reaching consensus agreement.
For each patient, the following items were assessed:
a) The number of AE liver lesions, with their maximum
diameter (measured on diffusion-weighted MR  images, b-
value = 50 s/mm2) and location according to Couinaud’s seg-
mental anatomy. Although Holzapfel et al. reported that DWI
was  also helpful to characterise small (≤1 cm)  FLLs [17], we  con-
sidered only AE lesions with a maximum diameter ≥1 cm due
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to the limited spatial resolution of ADC maps with the inher-
ent risk of measurement errors. Eight lesions were therefore
excluded and a total of 63 AE liver lesions ﬁnally included in
the analysis.
b) The presence of invasion of the portal and/or hepatic veins,
and/or intrahepatic bile ducts, as well as lobar atrophy or focal
capsular retraction.
c) The mean ADC of the surrounding liver parenchyma. This was
executed by placing a circular region of interest (ROI) of approx-
imately 1 cm2 in segment VI (whenever possible, n = 20) or
segment V (n = 2), directly on the ADC map. Three consecu-
tive measurements were performed and the median values
recorded.
For each AE lesion, the following features were subsequently
ssessed:
(a) The presence of cystic (including distinction between small and
large (≥2 cm)  cysts) and/or solid components, with categorisa-
tion according to Kodama’s classiﬁcation system [8]. The solid
component of the lesions was deﬁned as any portion that was
not as hyperintense as the cerebrospinal ﬂuid on T2-weighted
MR images [8,18].
b) The relative contrast enhancement, which was  calcu-
lated as follows on T1-weighted VIBE MR  images: (mean
SIportal venous − mean SIunenhanced)/mean SIunenhanced, where
SIportal venous and SIunenhanced are the mean signal intensities
measured in free-hand ROIs drawn in the lesion (and encom-
passing as much of the lesion as possible) on portal venous and
unenhanced phases, respectively. The measurements were
repeated three times consecutively and the median values
recorded.
(c) The presence of clustered microcalciﬁcations and/or large cal-
ciﬁcation foci on axial CT images.
d) The mean ADC (ADCtotal) of the lesion, with the mini-
mum  (ADCmin) and maximum (ADCmax) values. Firstly, the
readers agreed on the diffusion-weighted MR image (b-
value = 50 s/mm2) that best depicted the lesion. Then, they
drew a free-hand ROI in the lesion (again paying attention to
encompass as much of the lesion as possible), which was sub-
sequently copied and pasted on the corresponding ADC map.
Again, the measurements were repeated three times consecu-
tively and the median values of ADCtotal, ADCmin and ADCmax
recorded.
.4. Statistical analysis
The data were processed using two statistical software packages
JMP, version 10.0; SAS, Cary, NC, USA; and IBM SPSS Statistics,
ersion 21.0; IBM, Armonk, NY, USA). One-way analysis of vari-
nce (ANOVA) and Chi-squared tests were used to compare the
ontinuous and categorical variables between the ﬁve lesion types,
espectively. Furthermore, pairwise comparisons were performed
hen statistical signiﬁcance was reached. Pearson’s correlation
oefﬁcients (r) were used to assess potential associations between
he various MRI  features and ADCs. P-values <0.05 were considered
o be statistically signiﬁcant.
. Results
The mean (± standard deviation, SD) number of AE liver lesions
er patient was 2.9 ± 2.3 (range, 1–9). The average lesion size (max-
mum diameter) was 3.4 ± 3.0 cm (range, 1.0–14.2 cm). The lesion
istribution was as follows: segment I (n = 7, 11%), segment II (n = 9,
4%), segment III (n = 2, 3%), segment IVa (n = 4, 6%), segment IVbadiology 83 (2014) 625–631 627
(n = 3, 5%), segment V (n = 5, 8%), segment VI (n = 6, 10%), segment
VII (n = 13, 21%) and segment VIII (n = 14, 22%). Thirty-eight (60%)
lesions were located in the right lobe. Vascular invasion was found
in 18 (82%) patients, whereas 15 (68%) had an invasion of intra-
hepatic bile ducts. No patient had lobar atrophy or focal capsular
retraction. Fifty-ﬁve (87%) lesions were at least faintly enhanced
after contrast medium administration, whereas 8 (13%) showed
no enhancement. The mean relative contrast enhancement was
0.29 ± 0.22 (range, 0–1.09). Thirty-ﬁve (56%) lesions were at least
partly calciﬁed on CT. Clustered microcalciﬁcations were found in
34 (54%) lesions, large calciﬁcation foci in 6 (10%) and both patterns
in 4 (6%) lesions.
According to Kodama’s classiﬁcation system, we found 3 (5%)
type 1, 19 (30%) type 2 (Fig. 2), 17 (27%) type 3 (Fig. 3), 3 (5%) type 4
and 21 (33%) type 5 lesions. The MRI  (including DWI) ﬁndings as a
function of the AE lesion type are reported in Table 1. We  noted sta-
tistically signiﬁcant differences in size between the ﬁve lesion types
(p < 0.0001). Type 3 lesions were the largest (6.1 ± 2.2 cm), whereas
type 4 and 5 the smallest (1.3 ± 0.1 and 1.3 ± 0.3 cm,  respectively).
The lesion distribution in the liver and relative contrast enhance-
ment did not differ signiﬁcantly between the ﬁve lesion types
(p = 0.4951 and p = 0.5744, respectively). There were however sig-
niﬁcant differences in prevalence of calciﬁcations (p = 0.0002). Type
3 lesions were most frequently calciﬁed (n = 15, 88%), whereas
type 5 rarely (n = 4, 19%). Furthermore, AE lesions with a solid
component (type 2, 3 and 4) were signiﬁcantly more frequently
calciﬁed than those with a purely cystic component (type 1 and 5,
p < 0.0001).
The mean ADCtotal, ADCmin and ADCmax for all AE lesions were
1.73 ± 0.50, 0.76 ± 0.38 and 2.63 ± 0.76 × 10−3 mm2/s, respectively
(Table 1). The mean ADCtotal for type 1, type 2, type 3, type
4 and type 5 lesions were 1.97 ± 1.01, 1.76 ± 0.53, 1.73 ± 0.41,
1.15 ± 0.42 and 1.76 ± 0.44 × 10−3 mm2/s, respectively (Fig. 4a).
No signiﬁcant differences in ADCtotal were found between the
ﬁve lesion types, except for type 4 (p = 0.0363). Furthermore,
there were no signiﬁcant differences in ADCmin and ADCmax,
except that type 5 lesions had signiﬁcantly higher ADCmin
than all others (1.00 ± 0.36 × 10−3 mm2/s, p = 0.0003), whereas
type 4 signiﬁcantly lower ADCmax (1.59 ± 0.42 × 10−3 mm2/s,
p = 0.0137). The mean ADC of the surrounding liver parenchyma
was 1.21 ± 0.24 × 10−3 mm2/s (range, 0.66–1.69 × 10−3 mm2/s).
The mean ADCtotal for all AE lesions normalised with the
ADC of the surrounding liver parenchyma (ADClesion-to-liver) was
1.43 ± 0.47 × 10−3 mm2/s (range, 0.55–3.08 × 10−3 mm2/s). Again,
no signiﬁcant differences in ADClesion-to-liver were found between
the ﬁve lesion types, except for type 4 (p = 0.0415, Fig. 4b).
We noted a statistically signiﬁcant correlation between the
presence of solid components in AE lesions and low ADCmin
(r = 0.39, p = 0.0016). Moreover, there was a signiﬁcant correlation
between the presence of calciﬁcations and low ADCmin (r = 0.31,
p = 0.0159). Conversely, an inverse correlation was found between
lesion relative contrast enhancement and ADCtotal (r = −0.34,
p = 0.0072). Finally, there were no signiﬁcant correlations between
the presence of small or large cysts and ADCtotal (r = 0.08, p = 0.5418
and r = 0.04, p = 0.7813, respectively).
4. Discussion
AE should be diagnosed accurately and at an early stage to
enable optimal patient management. If left untreated, this parasitic
disease is usually fatal [1,3,4].US and CT remain the most widely used imaging techniques
for detecting AE liver lesions. While CT best depicts the char-
acteristic calciﬁcation pattern of these lesions, the assessment
of other lesion components is limited with this method [4–7].
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Fig. 2. 58-year-old man  with liver AE. Axial FS T2-weighted (a), gadolinium-enhanced (portal venous phase) FS T1-weighted VIBE (b) and FS diffusion-weighted (b-
value = 600 s/mm2) SS-EPI (c) MR images, with the corresponding ADC map  (d), depict a type 2 AE lesion (arrow) located in segment V. The lesion consists of multiple
small round cysts with a solid component (a), and is faintly enhanced (at the periphery) after intravenous gadolinium administration (b). Relative to the surrounding liver
parenchyma, the lesion remains hyperintense on the high b-value diffusion-weighted MR image (c), and is moderately hyperintense (ADCtotal = 1.61 × 10−3 mm2/s) on the
ADC  map  (d). Gross pathological examination (axial section) of the partial hepatectomy specimen (e) demonstrates the characteristic alveolar (multivesicular) structure
of  the AE lesion. Histopathological analysis (f) reveals metacestode vesicles (arrow) with an outer acellular laminar membrane (arrowhead), surrounded by an exuberant
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hanks to its excellent contrast resolution, MRI  is the best modal-
ty for visualising cystic and/or solid lesion components as well
s the invasion of vascular, biliary, and/or extrahepatic structures
8,19,20]; MRI  is therefore particularly helpful for preoperative
valuation [4,6,20]. Furthermore, Kodama’s classiﬁcation system
as established exclusively on the various MRI  patterns of AE
esions (Fig. 1) [8].
Cystic components, which consist of metacestode vesicles and
iquefaction necrosis, are characterised by low signal intensity on
1-weighted and high signal intensity on T2-weighted MRI  [4,8,18].
etacestode vesicles appear as small round cysts (included in type
, type 2, and type 3 lesions), whereas liquefaction necrosis is
isualised as large and/or irregular cysts (included in type 3 and
ype 5 lesions). In our study, type 5 lesions (liquefaction necrosis
ithout solid component) occurred most frequently (n = 21, 33%),
hile type 1 lesions (metacestode vesicles without solid compo-
ent) were the most rare (n = 3, 5%). Since the purely vesicular form
as been considered an initial stage of the disease [21], the small
umber of type 1 lesions encountered in the present investigation
ould mean that AE lesions progress rapidly to an advanced stage
r are detected late in the disease process.sin stain, original magniﬁcation 5×).
Solid components are characterised by low signal intensity
on T1-weighted and low to intermediate signal intensity on
T2-weighted MRI  [4,8,18]. They consist of coagulation necrosis,
granulomas, and/or calciﬁcations, and reﬂect the chronic ﬁbroin-
ﬂammatory host response. Type 2 (metacestode vesicles with a
solid component) and type 3 lesions (metacestode vesicles with
a solid component surrounding liquefaction necrosis) contain vari-
able amounts of solid components, whereas type 4 lesions consist
exclusively of solid tissue [8]. In our study, type 2 lesions were
the second most frequent lesion type (n = 19, 30%), closely fol-
lowed by type 3 lesions (n = 17, 27%); type 4 lesions were the
most rare (n = 3, 5%). Since type 2 and type 3 lesions together
accounted for more than half of the lesions (n = 36, 57%), we con-
clude that AE liver lesions occur most often as complex lesions, thus
emphasising the value of MRI  in the initial evaluation. Furthermore,
the ﬁbrotic tissue in AE lesions is not always composed of well-
perfused collagen, but is sometimes poorly vascularised, and may
include sclerosis. Thus, no or only subtle enhancement is seen after
intravenous administration of contrast medium [4–7]. However,
contrast enhancement has not been included in Kodama’s classi-
ﬁcation system, nor has the presence of calciﬁcations. The latter
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Fig. 3. 72-year-old man  with liver AE. Axial FS T2-weighted (a), gadolinium-enhanced (portal venous phase) FS T1-weighted VIBE (b) and FS diffusion-weighted (b-
value = 600 s/mm2) SS-EPI (c) MR images, with the corresponding ADC map  (d), depict a type 3 AE lesion (arrow) located in segment VII. The lesion is composed of multiple
small  round cysts with a solid component surrounding a large irregular cyst (a), and is faintly enhanced (at the periphery) after intravenous gadolinium administration (b).
Compared to the surrounding liver parenchyma, the lesion remains hyperintense on the high b-value diffusion-weighted MR image (c), and is moderately hyperintense
(ADCtotal = 1.78 × 10−3 mm2/s) on the ADC map  (d). Gross pathological examination (sagittal section) of the partial hepatectomy specimen (e) shows the typical alveolar (mul-
tivesicular) structure of the AE lesion. Histopathological analysis (f) reveals metacestode vesicles (arrow) with an outer acellular laminar membrane (arrowhead), surrounded
by  an exuberant ﬁbroinﬂammatory host response (* = ﬁbrosis, †  = inﬂammatory cells; periodic acid-schiff stain, original magniﬁcation 10×).
Fig. 4. Box-and-whisker diagrams illustrate the variations in ADCtotal (a) and ADClesion-to-liver (b) as a function of the AE lesion type. No statistically signiﬁcant dif-
ferences in ADCtotal (p = 0.3010) and ADClesion-to-liver (p = 0.2288) were found between the ﬁve lesion types, except for type 4, which had signiﬁcantly lower ADCtotal
(1.15 ± 0.42 × 10−3 mm2/s, p = 0.0363) and ADClesion-to-liver (0.95 ± 0.35 × 10−3 mm2/s, p = 0.0415) than all others.
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usually correspond to a near signal void on T1- and T2-weighted
MRI, and are therefore not easily detected with this technique
[19,20].
Over the past few years, DWI  has been increasingly used as an
adjunct to abdominal MRI  due to its ability to detect and charac-
terise FLLs without the use of gadolinium-based contrast agents
[10–12]. DWI  exploits the microscopic random motion of water
protons to measure the diffusion of ﬂuid in tissues [9,10]. Diffu-
sion is inversely related to cellularity, cell membrane integrity, and
lipophilicity; higher tissue cellularity leads to less diffusion and,
consequently, lower ADC values [22]. Conversely, in tissues with
low cellularity or disrupted cell membranes, diffusion is relatively
free or unimpeded. Thus, cellular or solid liver lesions (tumours,
abscesses, ﬁbrosis) are characterised by far lower ADC values than
purely cystic lesions, such as simple biliary cysts [11,12]. Our results
are in accordance with this principle, since type 1 lesions (metaces-
tode vesicles) had the highest ADCtotal (1.97 ± 1.01 × 10−3 mm2/s)
of the ﬁve lesion types, followed by type 5 (liquefaction necro-
sis) and type 2 lesions (1.76 ± 0.44 and 1.76 ± 0.53 × 10−3 mm2/s,
respectively). Using a similar DWI  protocol, Bruegel et al. reported
an ADC value of 3.02 ± 0.31 × 10−3 mm2/s for simple biliary cysts
[11]. In the present study, ADC values were clearly lower for
AE liver lesions, particularly for purely cystic lesions (type 1
and type 5). ADC measurements may  thus help distinguish AE
liver lesions from simple biliary cysts, which would be partic-
ularly helpful for type 5 lesions, as they mimic simple biliary
cysts.
Several studies have reported the utility of ADC measure-
ments in characterising FLLs [11,12,17,23–25]. In general, benign
liver lesions have higher ADC values than malignant lesions,
with a variable degree of overlap and ADC cutoffs ranging from
1.47 × 10−3 mm2/s to 1.60 × 10−3 mm2/s [11,12,17,23–25]. The
ADCtotal for each of the ﬁve AE lesion types were clearly above this
range (with the exception of type 4), highlighting the utility of ADC
measurements as a supplementary tool for distinguishing most AE
lesions from liver malignancies, especially those that resemble AE
in morphology. This is especially pertinent for cholangiocarcinoma,
which is often the main differential diagnosis at the initial detection
of AE [4,8,21]. A mean ADC of 1.31 ± 0.29 × 10−3 mm2/s for cholan-
giocarcinoma was  previously reported by Cui et al. [26], which is
clearly lower than the ADCtotal of all AE lesion types in the present
investigation (except type 4). However, Cui et al. only included the
extrahepatic type of lesion, and no results for intrahepatic cholan-
giocarcinoma have been published so far.
To our knowledge, the current work is the ﬁrst to report the DWI
ﬁndings in liver AE and investigate the usefulness of ADC values for
differentiating the ﬁve types of AE lesions. ADC values were not
helpful for this distinction, except for purely solid (type 4) lesions
(p = 0.0363). This type may  be easily distinguished from the other
types by measuring ADC values. Furthermore, the presence of solid
component within any type of AE lesion signiﬁcantly correlated
with a lower ADCmin (r = 0.39, p = 0.0016). Thus, solid content causes
a greater restriction in the diffusion of water protons compared to
that resulting from purely cystic AE lesions. This observation may
be due to several factors. Firstly, the presence of chronic ﬁbroin-
ﬂammatory tissue has been associated with low ADC values due to
its high cellularity and low proton density [10,22]. An association
between low ADC values and the presence of ﬁbroinﬂammatory
tissue is conﬁrmed by our observation that ADCtotal inversely cor-
related with relative contrast enhancement (r = −0.34, p = 0.0072);
this observation is most likely due to the accumulation of gadolin-
ium in the underlying ﬁbrotic component. Secondly, the presence
of cellular debris within the central necrosis has also been reported
to cause low ADC, primarily due to its high viscosity, as initially
demonstrated in hepatic abscess cavities [10,22,27]. Thirdly, the
presence of coagulation necrosis within the solid component leads
al of R
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o low ADC values due to the resulting paucity of water molecules
4].
Attributing distinct ADC values to the various morphologic com-
onents of AE liver lesions may  enable the detection of increased
r reduced disease activity via changes in ADC values, as has been
emonstrated with several hepatic and abdominal tumours [28].
ombined with MRI, we envision the use of these ADC values as a
iomarker during follow-up, a radiation-free and more available
lternative to F-18-ﬂuorodeoxyglucose (FDG) positron-emission
omography (PET) [6,29].
We  acknowledge the following limitations of our study. First,
mall numbers of type 1 (n = 3) and type 4 (n = 3) lesions were
valuated, compared with all other lesion types (n ≥ 17). Therefore,
dditional, larger studies are necessary to corroborate our results.
econd, ADC measurements are known to be highly variable, as
hey primarily depend on the b-values used during the acquisition
f diffusion-weighted sequences. We used a DW-SS-EPI sequence
nd b-values (50, 300 and 600 s/mm2) that were the same as those
sed in other studies [11,17]. Our results are therefore compara-
le with those of previous studies; for example, the ADC of the
urrounding liver parenchyma was 1.21 × 10−3 mm2/s, compared
ith 1.24 × 10−3 mm2/s for Bruegel et al. [11]. Finally, ADC mea-
urements are known to be subject to inter- and intraobserver
ariability [30], which is why we repeated all measurements three
imes in succession and only recorded the median values.
. Conclusion
MRI  performed with conventional sequences may  not enable
traightforward diagnosis of liver AE because the widely vary-
ng imaging results depend on the parasite’s growth stage [4,5].
urthermore, the inﬁltrative character of AE liver lesions mimics
low-growing primary or secondary liver malignancies. As demon-
trated in the present investigation, ADC values are helpful for
arrowing the differential diagnosis, particularly for excluding sim-
le biliary cysts and malignant lesions. However, ADC values were
ot useful for distinguishing the different AE lesion types, except
or one. Therefore, we recommend the routine addition of diffusion-
eighted sequences when investigating liver AE, as well as the use
f ADC values as a complementary tool for reaching the correct
iagnosis.
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